Literature DB >> 11385480

Olivieri to testify against Apotex in Europe.

L Bonetta.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11385480     DOI： 10.1038/88980

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  1 in total

1.  Patients' health or company profits? The commercialisation of academic research.

Authors:  Nancy F Olivieri
Journal:  Sci Eng Ethics       Date:  2003-01       Impact factor: 3.525
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.